Objective: Successful repair of segmental peripheral nerve defects remains a clinical challenge. The current clinical gold standard for such injuries is to use an autologous nerve graft, but this creates donor site morbidity with loss of sensation and potential scarring. Processed nerve allografts have been used to bridge segmental nerve gaps experimentally and clinically. However, in large nerve defects, functional outcomes are not comparable with autograft reconstruction yet; the longer the nerve gap, the poorer the outcome. Nerve architecture and the extracellular matrix (ECM) are preserved after processing; however, all cellular material including Schwann cells and axons are removed. The addition of supporting cells has been proposed to improve the decellularized allograft. Adipose-Derived Mesenchymal Stem Cells (AMSC) can potentially provide the necessary support for nerve regeneration due to local production of essential growth factors. While the mechanisms underlying the neurotrophic potential of AMSC remains unknown, it is postulated that the remaining ECM still has biological activity that influences the AMSC and their differentiation. Therefore, the purpose of this study was to quantitate the changes in gene expression profiles of the cells and quantify the actual produced growth factors after seeding the allograft with AMSC in vitro. Method: A total of 35 human nerve allografts were decellularized and seeded with human AMSC. At each time point (1, 3, 14, 21, and 28 days), total RNA was extracted, reverse transcribed into complementary DNA (cDNA), and quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was performed in combination with gene specific assays for genes essential for nerve regeneration including nerve growth factor (NGF), Brain-derived neurotrophic factor (BDNF), pleiotrophin vascular endothelial growth factor (PTN VEGF), and growth associated protein 43 (GAP43). Additional genes were analyzed to map AMSC characteristics including proliferation, apoptosis, myelinization, and ECM molecules. Production of growth factors was evaluated and quantified using enzyme-linked immunosorbent assay (ELISA). All samples were analyzed in triplicates and data were compared with AMSC cultured in media only. Results: Semiquantitative RT-PCR analysis showed that the interaction of the processed allograft and AMSC enhanced the expression of the neurotrophic factors NGF, BDNF, and GAP43. The expression of the angiogenic molecules, vascular endothelial growth factor A (VEGF-A) was also increased and remained significantly elevated at 28 days post seeding. Analysis of ECM-related gene expression showed that laminin subunit beta-2 (LAMB2), collagen type I alpha 1 (COL1A1), collagen type III alpha 1 (COL3A1), fibulin 1 (FBLN1), were significantly elevated until 21 days post seeding while after 28 days, these levels were normalized. Angiogenic factor cluster of differentiation 31 (CD31) and neurotrophic factor PTN expression were down regulated in the seeded cells. Quantitative results of the ELISA analysis are pending. We anticipate differences in growth factor levels released by the seeded allograft compared with the control expression levels. Conclusion: This study demonstrates that the remaining ECM of the decellularized nerve allograft has a stimulating effect on AMSC. Upon the seeding, secretion of neurotrophic and angiogenic factors were triggered; the cells cultured on the allograft showed enhanced levels of neurotrophic genes. This is hypothesized to be a consequence of specific cell-ECM interactions within the allograft. The combination of patient's own easily accessible, abundant supply of stem cells harvested from adipose tissue and the readily available processed nerve allograft is potentially a promising method for individualized peripheral nerve repair.
results of the ELISA analysis are pending. We anticipate differences in growth factor levels released by the seeded allograft compared with the control expression levels. Conclusion: This study demonstrates that the remaining ECM of the decellularized nerve allograft has a stimulating effect on AMSC. Upon the seeding, secretion of neurotrophic and angiogenic factors were triggered; the cells cultured on the allograft showed enhanced levels of neurotrophic genes. This is hypothesized to be a consequence of specific cell-ECM interactions within the allograft. The combination of patient's own easily accessible, abundant supply of stem cells harvested from adipose tissue and the readily available processed nerve allograft is potentially a promising method for individualized peripheral nerve repair. Objectives: Following tetraplegic spinal cord injury upper limb function may be improved by selective use of peripheral nerve transfers in isolation or in combination with tendon transfers. Early surgery is essential for nerves originating in the injured spinal cord segments due to Wallerian degeneration. Motor nerves arising from the infralesional segment of the injured spinal cord will have an intact peripheral neural pathway and nerve transfer may be undertaken beyond 12 months. This study evaluates the role of electromyography in planning and timing reconstruction. Methods: A consecutive series of 8 patients referred for consideration of nerve transfer surgery for restoration of upper limb function following tetraplegic spinal cord injury were evaluated with electromyography to establish volitional control, denervation, or evidence of reinnervation. For those patients undergoing surgery, further evaluation of intraoperative stimulation thresholds and motor response was recorded using a 4-point scale. Results: At our unit, we established a service for rehabilitation surgery of the upper limb after cervical spinal cord injury in 2013. Electromyography predicts lower motor unit lesions without reinnervation and early nerve transfer intervention may be offered to key target muscles in this group. For the C5/6 level tetraplegic with International Classification of Surgery of the Hand in Tetraplegia (ICHT) function at level 0 to 2, we recommend electromyography of extensor digitorum communis (EDC) and triceps to establish timing of reconstructive nerve transfers. Conclusions: Electromyography is an essential component of the preoperative assessment of patients for nerve transfer Nerve 95S reconstruction of the upper limb after spinal cord injury. For the C5/6 level tetraplegic with ICHT function at level 0 to 2, we recommend early electromyography of EDC and triceps between 3 and 6 months from injury to establish timing of reconstructive nerve transfers. Introduction: Information consent is a legal and ethical requirement when planning a surgical procedure. Information shared must be clear and honest to achieve a real process of shared decision making. Purpose: The purpose of this study was to validate an online tool of information consent. Method: This web application provided to the patient multimedia information resources (information about the pathology and its inherent risks of treatment) and allowed the surgeon to ensure suitable understanding of the patient with a conclusive evidence in a personal folder. We conducted a prospective study from February 2015 to February 2016. In all, 145 adult patients (48 men, 97 women, mean age 52 years) suffering an unilateral carpal tunnel syndrome (CTS) were included. They all had a personal mobile phone number for an e-signature. The questionnaire applied to CTS consisted of 18 items with binary answers yes/no, with a possibility of reinformation. Indeed, the patient was asked to reevaluate his answer with the possibility not to validate the issue. Each item must be checked and validated by the patient before discovering next one. The questions concerned the knowledge of the disease (physiopathology and causes) and its treatment (technical procedures), the risks (infection, reflex sympathic dystrophy, pain, lack of grip strength), and the expected benefits (disparition of paresthesia/pain, sensitivity of finger tips). At the end, the questionnaire was validated with an electronic signature via a SMS code. Results: The average duration of consent was 7 minutes 30 seconds (3-31). All patients validated their e-consent. In decreasing order, the items which needed reformulation were reflex sympathetic dystrophy (32%), the risk of injury to the median nerve (23%), the ability to adapt to the intraoperative gesture circumstances (10%), the hygiene regulations (4%), and a disagreement about the side to be treated (3%). There were no electronic signature failure. Conclusion: The use of this online application allowed patients to have access to informative and suitable content that seemed subjectively relevant (no invalidation). It allowed the patient to participate in its therapeutic options.
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Benefits of the "e-Informed
Thus, the surgeon could assess the quality of the information that he delivered and the insurance that the consent was obtained. Further questionnaires about other pathologies will be developed, thanks to this first experience.
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